<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83459</article-id><article-id pub-id-type="doi">10.7554/eLife.83459</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Genomic stability of self-inactivating rabies</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-49794"><name><surname>Ciabatti</surname><given-names>Ernesto</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9361-5992</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-295101"><name><surname>González-Rueda</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295102"><name><surname>de Malmazet</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295103"><name><surname>Lee</surname><given-names>Hassal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295104"><name><surname>Morgese</surname><given-names>Fabio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219942"><name><surname>Tripodi</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution>MRC Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-102322"><name><surname>Liberles</surname><given-names>Stephen D</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ciabatti@mrc-lmb.cam.ac.uk</email> (EC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>11</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83459</elocation-id><history><date date-type="received"><day>14</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>02</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Ciabatti et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ciabatti et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83459-v1.pdf"/><abstract><p>Transsynaptic viral vectors provide means to gain genetic access to neurons based on synaptic connectivity and are essential tools for the dissection of neural circuit function. Among them, the retrograde monosynaptic ΔG-Rabies has been widely used in neuroscience research. A recently developed engineered version of the ΔG-Rabies, the non-toxic self-inactivating (SiR) virus, allows the long term genetic manipulation of neural circuits. However, the high mutational rate of the rabies virus poses a risk that mutations targeting the key genetic regulatory element in the SiR genome could emerge and revert it to a canonical ΔG-Rabies. Such revertant mutations have recently been identified in a SiR batch. To address the origin, incidence and relevance of these mutations, we investigated the genomic stability of SiR <italic>in vitro</italic> and <italic>in vivo</italic>. We found that “revertant” mutations are rare and accumulate only when SiR is extensively amplified <italic>in vitro</italic>, particularly in suboptimal production cell lines that have insufficient levels of TEV protease activity. Moreover, we confirmed that SiR-CRE, unlike canonical ΔG-Rab-CRE or revertant-SiR-CRE, is non-toxic and that revertant mutations do not emerge <italic>in vivo</italic> during long-term experiments.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MRC-UP_1201/2</award-id><principal-award-recipient><name><surname>Tripodi</surname><given-names>Marco</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>STG-677029</award-id><principal-award-recipient><name><surname>Tripodi</surname><given-names>Marco</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Marie Sklodowska-Curie Fellowship</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowship</award-id><principal-award-recipient><name><surname>de Malmazet</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Cambridge Philosophical Society and St. Edmund's College</institution></institution-wrap></funding-source><award-id>Henslow Research Fellowship</award-id><principal-award-recipient><name><surname>González-Rueda</surname><given-names>Ana</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000833</institution-id><institution>Rosetrees Trust</institution></institution-wrap></funding-source><award-id>MBPhD fellowship</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Hassal</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ernesto Ciabatti, The SiR technology is patented by the UK Research and Innovation (WO2018203049A1)..</p></fn><fn fn-type="conflict" id="conf3"><p>Marco Tripodi, MT, Conceived the project, Secured funding, Wrote the manuscript..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the UK Animals (Scientific procedures) Act 1986 and European Community Council Directive on Animal Care. Animals were housed in a 12 hours light/dark cycle with food and water ad libitum.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data generated during this study are included in the manuscript and supporting files. The viral vectors used in this study have been previously described (Ciabatti, et al, 2017) and are available from Addgene. The raw NGS datasets have been deposited into NCBI's Sequence Read Archive (SRA) and are accessible through accession number PRJNA888353.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Ciabatti E</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>SiR genomic stability</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA888353">https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA888353</ext-link><comment>NCBI Sequence Read Archive, PRJNA888353</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83459-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>